How Retatrutide's Half-Life Shapes Split Dosing Retatrutide has the longest half-life of the three major GLP-1 compounds, approximately 6 days per Coskun et al
A new generation of these medications has transformed treatment possibilities for people who have type 2 diabetes (Ozempic, Mounjaro) or who have obesity or are overweight with a related health condition (Wegovy, Zepbound, Foundayo)
Current evidence continues to support the role of incretin-based therapiesparticularly tirzepatide, semaglutide, and liraglutidewhile emphasizing that treatment selection should be individualized according to the targeted metabolic, cardiovascular, hepatic, or functional benefit
This suggests that GLP-1 drugs could potentially reduce alcohol cravings in humans, providing a new treatment option for those struggling with alcohol addiction
Compounding pharmaceuticals is lawful, however they do not require FDA pre-market approval since they are not mass-produced for the general public
Importantly, they work best when combined with dietary changes and physical activity
